NP · Neptune Insurance Holdings

The thesis

Neptune Insurance Holdings is modestly more likely than not to beat the S&P 500 over the next three months. Revenue is growing far faster than the company's own 2027 guide, and the fourth-quarter 2026 report, expected around February 2027, settles whether written-premium growth holds.

The shares closed at $28.55 on 12 November 2026. That is 18.8% below the 52-week intraday high of $35.15 set on 29 July 2026, and 10.0% lower over three months in adjusted daily closes. The shares gave back the gain from the 20 October 2026 beat and raise while executives sold stock, then recovered part of it: the close of $27.91 on 6 November 2026 compares with $28.55 on 12 November 2026.

SEC Form 4 filings show the selling has not stopped. Matthew Duffy, the president and chief risk officer, sold 260,000 shares at an average of $28.12 between 9 November 2026 and 11 November 2026, filed 12 November 2026. Chief executive Trevor Burgess sold a further 171,285 shares at an average of $27.72 on 5 November 2026 and 6 November 2026 and 4,431 shares at $27.63 on 9 November 2026, both under Rule 10b5-1 plans, which are pre-arranged selling schedules. The shares rose through that selling, which says the supply is being absorbed at current prices.

Bullish and bearish views on Neptune Insurance Holdings Inc.

The bull case on Neptune Insurance Holdings Inc. (NP), in brief: third-quarter growth ran far above the guide. The bear case: insider selling is accelerating into the rebound.

Bull case

• Third-quarter growth ran far above the guide. Neptune's 20 October 2026 8-K shows revenue of $59.6 million, up 34.3%, and written premium of $132.7 million, up 31%. Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization, as the company adjusts it) was $36.8 million, a 61.7% margin.
• The forecast rose again. Full-year 2026 revenue guidance went from $199.0 million to $204.0 million on 20 October 2026, above a $202.142 million analyst estimate cited by Benzinga. Adjusted earnings per share of $0.17 beat a $0.16 estimate.
• The 2027 guide leaves out possible lifts. The outlook of about $238 million in revenue excludes any housing recovery, hurricane activity, acquisitions or new products, per Finviz coverage of the 20 October 2026 results.
• Debt is falling. Debt fell to $215 million from $240 million at 30 June 2026, and net leverage fell to 1.7 times from 2.1 times, per Finviz and Reinsurance News. A $100 million buyback authorized on 21 April 2026 saw no use in the third quarter.
• Analyst targets sit above the shares. MarketBeat listed a consensus target of $32.29 on 5 November 2026. Mizuho and Keefe, Bruyette & Woods each set $33 after the report.

Bear case

• Insider selling is accelerating into the rebound. Duffy's 260,000-share sale at an average of $28.12 over 9 November to 11 November 2026 follows his plan sales of 39,737 shares on 2 October 2026, 41,392 on 6 October 2026 and 84,441 on 8 October 2026, all per SEC Form 4.
• The CEO is a repeated seller. Burgess, who is also a 10% owner, sold 110,859 shares at an average of $29.26 and 119,577 at $28.95 between 30 October 2026 and 4 November 2026, then the November sales above, per SEC Form 4.
• Sponsor supply dwarfs insider buying. Massive counted $424.4 million of open-market insider sales across 9 filings in the 12 months to 26 October 2026, against $4.9 million of purchases. FTV and BSIV Hold 101 LP remain large holders.
• Growth is guided to slow. The 2027 guide of about $238 million is roughly 17% growth, against 34.3% in the third quarter. Revenue retention slipped to about 89% and premium per policy rose about 2% in the quarter, per Finviz.
• Sales face two named headwinds. Management's third-quarter commentary cited a slow real estate market and a residual slowdown from a quiet hurricane season. Both weigh on new flood-policy sales.
• Targets have started to drift. Morgan Stanley cut its target to $35 on 22 October 2026, and the shares did not hold the gain from the beat and raise.

Price setup

The shares closed at $28.55 on 12 November 2026. The 50-day average of the adjusted closes is $29.05, so the shares sit just under it. The 200-day average is $27.60, so they sit above it. The 52-week closing low is $17.14 on 12 February 2026, and the 52-week intraday high is $35.15 on 29 July 2026.

The $27.50 follow-on offering price of 13 May 2026 lies just under the 200-day average. Duffy's 6 October 2026 sale at $27.15 and Burgess's 9 November 2026 sale at $27.63 mark where executives sold in the lower part of the recent range.

Supply shows in the filings. Executive plan sales have run from 2 October 2026 through 11 November 2026, and sponsors have sold multi-million-share blocks over the past year. No earnings report falls inside the next 30 days.

Catalysts ahead

• 30 November 2026: End of the Atlantic hurricane season. A close with no major landfall ends the year's loss window, and it confirms the quiet season management cited as a drag on sales.
• 1 December 2026: Contingent commissions end on active programs, per Neptune's third-quarter commentary. Management and third-party coverage cite this as a possible lift to margin in the 2027 guide.
• ~14 December 2026 (est.): Further Form 4 filings from executives, directors or sponsors. More sales would extend the share supply seen since 2 October 2026, including the CEO's and president's plan sales.
• ~24 February 2027 (est.): Fourth-quarter 2026 results and 10-K, after which the CFO transition takes effect. Shows whether written-premium growth holds near 30% against a 2027 revenue guide of about 17%.

What would change the view

A daily close below $25.00, which would take the shares well under the $27.50 price of the May 2026 follow-on offering and show the market rejecting the growth case. Fourth-quarter 2026 written-premium growth under 20% would also break the case.

The risks this note tracks, each with what would confirm it:

• Growth steps down toward the 17% pace guided for 2027 faster than the market expects. Confirmed by: fourth-quarter written-premium growth under 20%, or revenue retention falling below the 89% reported for the third quarter of 2026.
• Executive and sponsor share sales continue into the current price range. Confirmed by: more SEC Form 4 sales by Trevor Burgess or Matthew Duffy, or another registered secondary from FTV or BSIV Hold 101 LP.
• A slow real estate market and a quiet hurricane season weaken new flood-policy sales. Confirmed by: fourth-quarter new-business commentary citing weaker sales, or a cut to the $204 million 2026 revenue forecast.
• A severe hurricane landfall reprices the private-flood book and its reinsurance terms. Confirmed by: a major Gulf or Southeast landfall before 30 November 2026, followed by carrier or reinsurance commentary.
• Analyst targets drift lower because the shares did not hold the gain from a beat and raise. Confirmed by: further target cuts like Morgan Stanley's to $35 on 22 October 2026, or the shares closing below the $27.50 offering price of 13 May 2026.
• Federal flood-insurance policy narrows Neptune's price and coverage advantage over the National Flood Insurance Program. Confirmed by: a reauthorization or rate-reform measure advancing in Congress that changes program pricing or coverage limits.

What it trades with

Neptune is a private-flood managing general agent. It earns fees on policies placed with carriers, so its shares track property-and-casualty underwriters loosely. The main drivers are company-specific: home-sale volumes, which feed new flood policies; hurricane headlines from June to November; and federal flood-insurance policy, which sets the price of the competing National Flood Insurance Program. Sponsor and executive share sales add a supply factor that broad insurance indices do not carry.